• In Vivo Screening Reveals BET/HDAC Inhibition Synergy in PDA

  2026-04-28

  This study introduces a concerted in vitro and in vivo screening platform leveraging Rgs16::GFP as a rapid biomarker to identify chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). The findings highlight the synergistic effect of BET and HDAC inhibition with gemcitabine, providing a framework for more efficient preclinical evaluation of epigenetic therapies.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-04-27

  MTT stands at the forefront of colorimetric cell viability assessment, integrating precise metabolic activity measurement with unparalleled workflow reproducibility. This guide details best practices, optimization, and troubleshooting for MTT-based assays, empowering labs to achieve sensitive, reliable results across diverse research scenarios.

• Adenosine Triphosphate in Advanced Cellular Metabolism Resea

  2026-04-27

  Adenosine triphosphate (ATP) from APExBIO empowers researchers to dissect mitochondrial regulation, purinergic signaling, and cell energetics with exceptional reliability. This article provides actionable workflows, data-driven troubleshooting, and new insights from recent discoveries into mitochondrial enzyme regulation—enabling precise, reproducible results in both classic and cutting-edge applications.

• Optimizing mRNA Research with HyperScribe™ Poly (A) Tailing

  2026-04-26

  This article explores laboratory challenges in RNA polyadenylation and demonstrates how the HyperScribe™ Poly (A) Tailing Kit (SKU K1053) from APExBIO addresses issues of mRNA stability, translation efficiency, and reproducibility. Drawing on published data and real-world assay needs, it guides researchers through best practices and protocol optimization, grounded in evidence and workflow expertise.

• Eltanexor (KPT-8602): Shifting Paradigms in XPO1-Targeted On

  2026-04-25

  Eltanexor (KPT-8602), a second-generation, oral XPO1 inhibitor, is transforming translational cancer research by mechanistically disrupting nuclear export and Wnt/β-catenin signaling. This article provides deep mechanistic insight, comparative context, and actionable guidance for oncology researchers, highlighting recent advances in acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and colorectal cancer models. Special emphasis is placed on how APExBIO's Eltanexor enables sophisticated experimental design and bridges the gap between mechanistic understanding and clinical innovation.

• BCA Protein Assay Kit: Precision Bicinchoninic Acid Quantifi

  2026-04-24

  The BCA Protein Assay Kit (APExBIO, K4101) delivers sensitive, reproducible protein quantification using the bicinchoninic acid (BCA) method. Its robust colorimetric detection (562 nm) enables accurate protein measurement from 0.5 μg to 2000 μg/mL, supporting workflows in molecular biology and neuroinflammation research.

• O-GlcNAcylation Modulates OTX2 Stability and Aggregation Dyn

  2026-04-24

  This study elucidates how O-GlcNAcylation of OTX2, a critical homeobox transcription factor, regulates its stability and aggregation through interplay with autophagy and chaperone-mediated proteostasis. The findings demonstrate that O-GlcNAc modifications enhance OTX2 solubility, limit aggregation, and impact cell proliferation, offering new mechanistic insights into neurodevelopmental and oncogenic processes.

• Pharmacokinetics of Temafloxacin: Implications for Antimicro

  2026-04-23

  This review of temafloxacin’s pharmacokinetics highlights its high oral bioavailability, extensive tissue distribution, and long elimination half-life, supporting convenient single or twice-daily dosing. The insights inform rational dosing strategies in antimicrobial therapy and provide a comparative context for evaluating related antibiotics such as Sulfamonomethoxine.

• miR-18a/ALOXE3 Axis Regulates Ferroptosis and Migration in G

  2026-04-23

  This study uncovers how miR-18a promotes glioblastoma by downregulating ALOXE3, which diminishes ferroptotic cell death and enhances tumor cell migration via 12-HETE signaling. These findings provide mechanistic insight into lipid metabolic regulation in GBM and suggest potential targets for future therapeutic strategies.

• Live-Dead Cell Staining Kit: Technical Guide for Reliable As

  2026-04-22

  The Live-Dead Cell Staining Kit (K2081) enables precise discrimination of live and dead cells in cultured populations, addressing a core challenge in viability and cytotoxicity assays. This kit is optimal for fluorescence-based workflows in research but should not be used in diagnostic or medical applications.

• RITA (NSC 652287): Precision Tool for Renal Carcinoma Workfl

  2026-04-22

  RITA (NSC 652287) is a selective MDM2-p53 interaction inhibitor that delivers nanomolar potency and robust tumor regression in renal carcinoma models. This guide translates the latest in vitro cancer drug evaluation methods into actionable workflows, troubleshooting strategies, and protocol enhancements for maximizing RITA's impact in apoptosis and tumor xenograft research.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S

  2026-04-21

  The Lipid Peroxidation (MDA) Assay Kit from APExBIO empowers researchers to quantify malondialdehyde with exceptional sensitivity and reproducibility across biological matrices. With dual colorimetric and fluorescence readout, it advances oxidative stress biomarker discovery and translational studies, especially in the context of ferroptosis and therapeutic resistance.

• Diclofenac in Intestinal Organoid-Based Pharmacokinetic Assa

  2026-04-21

  Explore how Diclofenac, a non-selective COX inhibitor, enables advanced pharmacokinetic and inflammation research using human intestinal organoids. This article uniquely bridges compound characterization with practical assay guidance.

• RNA Pol II Inhibition Triggers Apoptosis via Loss of Pol IIA

  2026-04-20

  Harper et al. (2025) demonstrate that cell death from RNA Pol II inhibition results from the loss of hypophosphorylated RNA Pol IIA, not from passive mRNA decay as previously thought. This mechanistic insight reshapes our understanding of apoptosis in response to transcriptional blockade and suggests new directions for cancer therapy research.

• Tropisetron Hydrochloride: Precision Tools for 5-HT3 Pathway

  2026-04-20

  Explore the advanced utility of Tropisetron Hydrochloride as a selective 5-HT3 receptor antagonist in neuroscience receptor modulation and transporter interaction studies. This article offers a uniquely practical, assay-focused perspective on optimizing serotonin receptor signaling research.

449 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page